
    
      pharmacokinetic profile, safety, and tolerability of a single intravenous (IV) dose of
      delafloxacin in normal healthy subjects and subjects with mild, moderate, or severe hepatic
      impairment. AUC0-t, AUC0 inf, Cmax, Tmax, Î»z, t1/2, MRTinf, CL, CLnr, Vss, Vz
    
  